Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | AMNI | Common Stock Purchase Option | Award | $0 | +500K | +384.62% | $0.00 | 630K | Jun 4, 2021 | common stock | 500K | $0.50 | Direct | F2 |
transaction | AMNI | Convertible Promissory Note Payable | Other | $5.26K | 641K | Mar 31, 2021 | common stock | 10.5K | $0.50 | Direct | F1 | |||
transaction | AMNI | Warrant to purchase Common Stock | Other | $0 | +1.05M | +164.15% | $0.00 | 1.69M | Mar 31, 2021 | common stock | 1.05M | $0.50 | Direct | F1 |
Id | Content |
---|---|
F1 | On March 31, 2021 the Reporting Person agreed to exchange accrued but unpaid compensation totaling $525,708 for a 3% convertible promissory note payable with a principal balance of $5,257 which is convertible into 10,514 shares of common stock and maturity date of March 31, 2026. In addition, the Reporting person was issued detachable warrants to purchase a total of 1,051,416 shares of common stock at $0.50 per share. The Reporting Person has agreed to not exercise his right to convert the promissory note or exercise the common stock purchase warrants at anytime whereby the Reporting Person would beneficially own more than 4.99% or with prior notice 9.99% of the Company's outstanding common stock. |
F2 | On June 4, 2021 the Reporting Person was granted options to purchase 500,000 shares of common stock at an exercise price of $0.50 per share with a termination date of June 4, 2031. Such common stock purchase options vest on June 4, 2022 contingent upon the Reporting Person continued service to the Company at such point in time. |